RT Journal Article
SR Electronic
T1 Adherence to the 2016 PAHO Clinical Practice Guideline on Dengue in a Hospital in Northern Peru, 2022-2023
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.25.24310969
DO 10.1101/2024.07.25.24310969
A1 León Jiménez, Franco E.
A1 Mendoza-Farro, Nataly BF.
A1 Montoya Reategui, Adriana
A1 Inga-Chero, Joel Emmanuel
A1 Dioses Diaz, Karim
A1 Barranzuela-Herrera, Moisés
A1 Cavalcanti Ramírez, Sophia
A1 Moyano, Luz M.
A1 de Neuroepidemiology and Science of life working group
YR 2024
UL http://medrxiv.org/content/early/2024/07/25/2024.07.25.24310969.abstract
AB Background Effective dengue management enhances the chances of survival. The level of adherence to the suggestions in northern Peru is uncertain. The primary aim of the study was to assess adherence to the 2016 PAHO guideline on dengue in a hospital located in northern Peru during the period from 2022 to 2023.Methodology/principal findings The study performed a cross-sectional design and exploratory analysis, reviewing 141 medical records. Fifty-four percent were from 2023; 65.9% were from women; 46.1% came from another healthcare center; 76.6% had diagnosis of dengue with warning signs; 20.7% had severe dengue; and 18.44% died. We found at least one error in the classification of severity and/or treatment in non-hospital healthcare facilities (91.5%), triage (88.5%), and uviclin/observation (52.6%). Errors in classification and inadequate hydration in the non-hospital healthcare centers, triage, and uviclin/observation were: 35.8%/53.7%, 30.6%/76.6%, and 10.1%/45.6%, respectively. Persistent errors were inadequate hydration in triage (76.86%) and urinary flow in the center (73.13%). In a bivariate analysis, mortality was associated with older age (p = 0.035), having a case from 2023 (p = 0.0073), having a case from the study hospital (p = 0.083), and having severe dengue (p<0.001). In the multivariate analysis, only severe dengue (OR 318.4, 95% IC [33.8-2996], p<0.001) was associated with mortality.Conclusions/significance We found a high frequency of misclassification and management errors in these three scenarios, but they were not associated with higher mortality.Author summary According to the PAHO 2016 Dengue Guidelines, this descriptive study found deficiencies in the diagnosis of severity and treatment in a public hospital of the Ministry of Health of Peru, located in the region with the highest dengue incidence rate in 2023. We identified these deficiencies in the pre-hospital phase, as well as in the emergency, observation, and dengue management units, which had a high mortality rate of 18%. While it is true that management errors were not associated with higher mortality in the exploratory analysis, study biases may explain this result. We must take these findings into account when investigating the effectiveness of the health worker training that took place between 2023 and 2024, employing a master-class methodology and awaiting a before and after analysis to gauge its impact on knowledge. The need for improvements in health data management highlights the need to digitize information and electronic health records.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThe author(s) received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Ethics Committee of the Teaching and Research Unit at the Hospital de la Amistad, Peru-Korea Santa Rosa, approved the study protocol. We delivered a final report to the hospital's general management and shared the results with the authorities and the hospital's dengue team.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe database has been included in the supplementary information.